Airway Therapeutics Inc.

Address: 1200 Johnson Ferry Road Suite 300

Sponsor Overview

assignment

Specializations

Pulmonary and Respiratory Therapeutics

Airway Therapeutics Inc. concentrates its research efforts on developing innovative treatments for severe respiratory conditions and lung diseases. The company's clinical investigation portfolio demonstrates a commitment to addressing critical pulmonary pathologies that significantly impact patient quality of life and survival outcomes.

Acute Respiratory Distress Syndrome
Chronic Obstructive Pulmonary Disease
Respiratory Failure Management
Airway Protection Mechanisms

The sponsor's therapeutic development programs focus on novel approaches to restore and maintain airway function, targeting both acute exacerbations and chronic progressive respiratory disorders through specialized biological interventions.

Critical Care Medicine

The organization pursues research in intensive care medicine, with particular emphasis on life-threatening conditions requiring immediate medical intervention. Their clinical programs address scenarios where patients experience severe physiological compromise and require advanced supportive care measures.

Ventilator-Associated Complications
Acute Lung Injury
Multi-Organ Support Systems
Critical Illness Recovery

Through multinational clinical investigations, the sponsor explores therapeutic strategies aimed at improving outcomes in critically ill patients, particularly those with compromised respiratory mechanics and impaired gas exchange.

Protein-Based Therapeutics

Airway Therapeutics Inc. demonstrates expertise in the development of recombinant protein therapies designed to address deficiencies or dysfunctions in natural protective mechanisms. The company's research platform emphasizes biologically derived therapeutic agents that can modulate disease processes at the molecular level.

Enzyme Replacement Therapy
Protective Protein Supplementation
Biological Barrier Function Enhancement
Innate Immunity Modulation

The sponsor's therapeutic approach centers on restoring physiological balance through administration of specialized proteins that support airway defense mechanisms and promote tissue protection in compromised pulmonary environments.

Trial Name	Country	Status
Efficacy of Zelpultide Alfa in Preventing Bronchopulmonary Dysplasia in High-Risk Preterm Neonates: A Phase 3 Randomized, Double-Blind, Multicenter Study	Belgium Czechia France Germany Italy Poland Portugal Spain	Recruiting